
Join to View Full Profile
300 Pasteur DrStanford, CA 94305
Phone+1 650-723-4000
Dr. Chiang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Ryan Chiang, MD, is an Internal Medicine specialist based in Stanford, CA. He completed his residency in Internal Medicine at Stanford Health Care-Sponsored Stanford University from 2020 to 2023, following his graduation from Duke University School of Medicine in 2020. Dr. Chiang is currently a Clinical Assistant Professor at Stanford Health Care. His research work includes several publications focusing on racial diversity in FDA trials and immunotherapy for cancer, with articles featured in journals such as Cancer Investigation and Oncotargets and Therapy. His work has been cited multiple times by other publications.
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 2020 - 2023
- Duke University School of MedicineClass of 2020
Certifications & Licensure
- CA State Medical License 2023 - 2025
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 2 citationsRacial Diversity and Reporting in United States Food and Drug Administration Registration Trials for Thoracic Malignancies from 2006 to 2020.Ryan S Chiang, Aakash Desai, Michael J Glover, Gavin Hui, Kavitha J Ramchandran
Cancer Investigation. 2023-01-01 - 53 citationsEfficacy of enfortumab vedotin in advanced urothelial cancer: Analysis from the Urothelial Cancer Network to Investigate Therapeutic Experiences (UNITE) study.Vadim S Koshkin, Nicholas Henderson, Marihella James, Divya Natesan, Dory Freeman
Cancer. 2022-03-15 - 4 citationsMetastatic Parotid Gland Carcinoma With ERBB2 Amplification With Complete Response to Fam-Trastuzumab Deruxtecan.Navika D Shukla, Ryan S Chiang, Alexander D Colevas
Journal of the National Comprehensive Cancer Network. 2022-02-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: